Profile avatar
stemcellevidence.bsky.social
Curating the evidence in haematopoietic stem cell transplantation. Free monthly Stem Cell Evidence Alert http://bit.ly/2HMQtb5 @[email protected] #MedSky
76 posts 111 followers 486 following
Prolific Poster

New from the #Transfusion Evidence Alert: Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial by Anker et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

New from the #StemCellEvidence Alert: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation by Aubrey et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis by Hernandez-Boluda et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: The cost-effectiveness of interventions used for the screening, diagnosis and management of anaemia in pregnancy: A #systematicreview by Allen et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

The latest #StemCellEvidence monthly alert is out! See all the top 10 articles here: www.stemcellevidence.com/alerts/latest Each one has an easy-to-read PICO summary. #MedSky

The #Transfusion Evidence Round-Up: #InternationalClinicalTrialsDay 2025 is out! See the top 10 articles here: www.transfusionevidencelibrary.com/alerts/latest #MedSky

From the #StemCellEvidence Alert: HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study by Riller et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT by Polverelli et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Transplant Outcomes Using Older Matched Sibling Donors Compared to Young Alternative Donors: A CIBMTR Analysis by Nath et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Monitoring the KMT2A gene post-chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation by Liu et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation #MedSky

New from #StemCellEvidence: Immune reconstitution dynamics after unrelated allogeneic transplantation with post-transplant cyclophosphamide compared to classical immunosuppression with anti-thymocyte globulin (...) by Kerbauy et al www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Haploidentical Bone Marrow Transplantation for #SickleCellDisease by Kassim et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #Transfusion Evidence Library: Implementation strategies for WHO guidelines to prevent, detect, and treat postpartum hemorrhage by Semrau et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

New from #StemCellEvidence: Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT by DeFilipp et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease by Wilkinson et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations by Baranwal et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD by Zhao et al. www.stemcellevidence.com/alerts/artic... #MedSky

The latest #StemCellEvidence monthly alert is out! See all the top 10 articles here: www.stemcellevidence.com/alerts/latest Each one has an easy-to-read PICO summary. #MedSky

Find the latest top articles in haematopoietic #stemcell transplantation here: www.stemcellevidence.com/articles/sea... #MedSky

From the #Transfusion Evidence Alert: Multicentre randomised controlled trial of a self-assembling haemostatic gel to prevent delayed bleeding following endoscopic mucosal resection (PURPLE Trial) by Drews et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

New vacancy! We're looking for a Business Manager to join our team. Interested? See below for more details and how to apply (deadline 6th May) www.jobs.nhs.uk/candidate/jo...

New from #StemCellEvidence: Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation by Wada et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: Transfusion of blood and blood products for the management of postpartum haemorrhage by Williams et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide (...) by Sanz et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT by Passweg et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Differential Clinical and Immunological Impacts of Anti-T-Lymphocyte Globulin (ATLG) vs. Anti-Thymocyte Globulin (ATG) in Preventing Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation (...) by Notarantonio et al. #MedSky

New from #StemCellEvidence: Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis by Nedumannil et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Clinical impact of donor telomere length after umbilical cord blood transplantation by Nagao et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: Therapeutic plasma exchange accelerates immune cell recovery in severe #COVID-19 by Guironnet-Paquet et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

New from #StemCellEvidence: Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis by Luque Paz et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Donor-specific anti-HLA antibodies (DSAs) in patients undergoing allogeneic hematopoietic stem cell transplantation from mismatched donors on behalf of GITMO and AIBT by La Rocca et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert Which is the best storage temperature to preserve the haemostatic quality of non-leukoreduced whole blood units collected under a military emergency protocol - Cold or room temperature? by Degueldre et al www.transfusionevidencelibrary.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Pre-Transplant MRD Does Not Seem to Impact Survival in NPM1-Mutated AML Undergoing Allogeneic Stem Cell Transplantation by Fraccaroli et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Clinical-genomic profiling of MDS to inform allo-HSCT: Recommendations from an international panel on behalf of the EBMT by Gurnari et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: Liberal vs. restrictive transfusion strategies for acute brain injury: a #systematicreview and frequentist-Bayesian #metaanalysis by Blot et al. www.transfusionevidencelibrary.com/alerts/artic... #MedSky

The latest #StemCellEvidence monthly alert is out! See all the top 10 articles here: www.stemcellevidence.com/alerts/latest Each one has an easy-to-read PICO summary. #MedSky

Did you know that you can search the top articles featured in previous #StemCellEvidence alerts, by month? #MedSky

From the #StemCellEvidence Alert: Diagnosing Acute Graft-Versus-Host Disease in Children Undergoing Hematopoietic Stem Cell Transplantation-Comparison of the Modified Glucksberg Criteria Versus the MAGIC Criteria by Weischendorff et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Common Hereditary Variants of the APOE Gene and Posttransplant Outcome in Acute Myeloid Leukemia by Ronnacker et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease by Meyer et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #Transfusion Evidence Alert: #Tranexamicacid for preventing #postpartumhaemorrhage after vaginal birth by Rohwer et al. www.transfusionevidencelibrary.com/alerts/artic... #systematicreview #MedSky

New from #StemCellEvidence: Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML by Levis et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation by Kongtim et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI) by Fox et al. www.stemcellevidence.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT by DeFilipp et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Salvage Autologous Transplant in Relapsed Multiple Myeloma: Long-Term Follow-Up of the Phase 3 GMMG ReLApsE Trial by Baertsch et al. www.stemcellevidence.com/alerts/artic... #MedSky

From #Transfusion Evidence Library: Transfusion efficacy of leucoreduced packed red blood cells prepared by two different methods: A randomized controlled trial in transfusion-dependent thalassaemia patients (FUEL trial) by Arunkumari et al www.transfusionevidencelibrary.com/alerts/artic... #MedSky

From the #StemCellEvidence Alert: Comparison of Outcomes of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Older Versus Younger Patients by Adoncecchi et al. www.stemcellevidence.com/alerts/artic... #MedSky

New from #StemCellEvidence: Clearance of Driver Mutations after Transplantation for Myelofibrosis by Gagelmann et al. www.stemcellevidence.com/alerts/artic... #MedSky